Carregant...
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists
Given the intersection between diabetes mellitus and cardiovascular disease (CVD), pharmacologic agents used to treat type 2 diabetes mellitus must show cardiovascular safety. Comorbid conditions, including heart failure and chronic kidney disease, are increasingly prevalent in patients with diabete...
Guardat en:
| Publicat a: | J Am Coll Cardiol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219531/ https://ncbi.nlm.nih.gov/pubmed/32327107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2020.02.056 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|